Skip to main content
Medical information Clinical review pending

Genetic Testing

AMTN Gene Amelotin Deficiency Genetic Test

Genetic test using Next Generation Sequencing (NGS) to identify mutations in the AMTN gene, which can be linked to dental enamel disorders and other related conditions. Confirm with the laboratory before booking.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Blood sample (EDTA tube) or Saliva sample (specific collection kit). Confirm with the laboratory before booking.
Results
Results are typically available within 3 to 4 weeks. Confirm with the laboratory before booking.
Preparation
No special preparation is typically required for a blood or saliva sample. Confirm with the laboratory before booking.
Test priceKSh 40,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the AMTN Gene Amelotin Deficiency Genetic Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Individuals with a family history of dental enamel disorders.
  • ✓Patients with unexplained dental enamel defects.
  • ✓Individuals with symptoms suggestive of conditions linked to AMTN gene mutations.
  • ✓Diagnosis confirmation for suspected AMTN-related disorders.
02

In plain language

What this test helps you understand

This test identifies mutations in the AMTN gene, which may be associated with enamel hypoplasia and other related disorders. It can aid in diagnosis, understanding disease risk, and informing management strategies.
The AMTN Gene Amelotin Deficiency NGS Genetic DNA Test is designed to detect mutations in the AMTN gene. This gene is important for enamel development in teeth. Deficiencies or mutations can potentially lead to various conditions affecting dental health, bone structure, and skin. Understanding these genetic factors can be important for diagnosis and management. This test uses advanced Next Generation Sequencing (NGS) technology to analyze your DNA for specific changes in the AMTN gene. Results can help provide insights into the underlying cause of certain health conditions. Consult with your doctor to determine if this test is appropriate for you.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo special preparation is typically required for a blood or saliva sample. Confirm with the laboratory before booking.
SampleBlood sample (EDTA tube) or Saliva sample (specific collection kit). Confirm with the laboratory before booking.
MethodologyNext Generation Sequencing (NGS) of the AMTN gene.
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test analyzes specific regions of the AMTN gene. It may not detect all possible mutations, including those in non-coding regions or large structural variations. Results should be interpreted alongside clinical findings. Confirm with the laboratory before booking.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

The AMTN gene provides instructions for making a protein called amelotin, which is important for the proper formation of tooth enamel.
Mutations in the AMTN gene have been linked to conditions affecting tooth enamel development, such as enamel hypoplasia. Other potential associations are under investigation.
The test uses NGS technology, which is highly accurate for detecting known mutations within the analyzed regions of the AMTN gene. However, it may not detect all possible genetic changes.
Your doctor or a genetic counselor will help you understand the results in the context of your health history and symptoms. They can discuss potential implications and next steps.
Insurance coverage varies. Please check with your insurance provider regarding coverage for genetic testing.
If the test identifies a genetic mutation, genetic counseling can help you understand the implications for yourself and your family members, including potential risks for future children.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp